Why do some depressed outpatients who are in remission according to the hamilton depression rating scale not consider themselves to be in remission?

Journal of Clinical Psychiatry

Volumn 73, Issue 6, 2012, Pages 790-795

  Zimmerman, Mark ^a,b   Martinez, Jennifer A ^a,b   Attiullah, Naureen ^a,b   Friedman, Michael ^a,b   Toba, Cristina ^a,b   Boerescu, Daniela A ^a,b   Rahgeb, Moataz ^a,b  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; CLINICAL DECISION MAKING; CONTROLLED STUDY; COPING BEHAVIOR; FEMALE; FUNCTIONAL DISEASE; HAMILTON SCALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OUTCOME ASSESSMENT; OUTPATIENT; PATIENT ATTITUDE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; REMISSION; SCORING SYSTEM; SELF REPORT;

EID: 84863548660     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.11m07203     Document Type: Article

References (42)

1. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. doi:10.136/jnp.23.1.56 PubMed
2. Zimmerman M, Coryell W, Pfohl B. The treatment validity of DSM-III melancholic subtyping. Psychiatry Res. 1985;16(1):37-43. doi:10.1016/0165- 1781(85)9026-5 PubMed (Pubitemid 15245201)
3. Keller MB. Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond. JAMA. 2003; 289(23):3152-3160. doi:10.101/jama.289.23.3152 PubMed (Pubitemid 37432891)
4. Frank E, Prien RF, Jarrett RB, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiatry. 1991;48(9): 851-855. PubMed
5. Rush AJ, Kraemer HC, Sackeim HA, et al ACNP Task Force. Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology. 2006;31(9):1841-1853. doi:10.1038/sj.np.130131 PubMed
6. Paykel ES, Ramana R, Cooper Z, et al. Residual symptoms after partial remission: an important outcome in depression. Psychol Med. 1995; 25(6):1171-1180. doi:10.1017/S03291703146 PubMed
7. Van Londen L, Molenaar RP, Goekoop JG, et al. Three- to 5-year prospective follow-up of outcome in major depression. Psychol Med. 1998;28(3):731-735. doi:10.1017/S032917970646 PubMed (Pubitemid 28241305)
8. Pintor L, Gastó C, Navarro V, et al. Relapse of major depression after complete and partial remission during a 2-year follow-up. J Affect Disord. 2003;73(3):237-244. doi:10.1016/S0165-0327(01)0480-3 PubMed (Pubitemid 36120734)
9. Thase ME, Simons AD, McGeary J, et al. Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment. Am J Psychiatry. 1992;149(8):1046-1052. PubMed
10. Miller IW, Keitner GI, Schatzberg AF, et al. The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. J Clin Psychiatry. 1998;59(11):608-619. doi:10.408/JCP.v59n108 PubMed (Pubitemid 28555422)
11. Trivedi MH, Corey-Lisle PK, Guo Z, et al. Remission, response without remission, and nonresponse in major depressive disorder: impact on functioning. Int Clin Psychopharmacol. 2009;24(3):133-138. doi:10.1097/YIC.0b013e328327614 PubMed
12. Romera I, Perez V, Menchón JM, et al. Social and occupational functioning impairment in patients in partial versus complete remission of a major depressive disorder episode: a six-month prospective epidemiological study. Eur Psychiatry. 2010;25(1):58-65. doi:10.1016/j.eurpsy.209.02.07 PubMed
13. Papakostas GI, Petersen T, Denninger JW, et al. Psychosocial functioning during the treatment of major depressive disorder with fluoxetine. J Clin Psychopharmacol. 2004;24(5):507-511. doi:10.1097/01.jcp.0138761.85363.d5 PubMed (Pubitemid 39274204)
14. Ballenger JC. Clinical guidelines for establishing remission in patients with depression and anxiety. J Clin Psychiatry. 1999;60(suppl 22):29-34. PubMed (Pubitemid 30107953)
15. Nierenberg AA, Wright EC. Evolution of remission as the new standard in the treatment of depression. J Clin Psychiatry. 1999;60(suppl 22): 7-11. PubMed (Pubitemid 30107949)
16. Ferrier IN. Treatment of major depression: is improvement enough? J Clin Psychiatry. 1999;60(suppl 6):10-14. PubMed (Pubitemid 29210625)
17. Rush AJ, Crismon ML, Toprac MG, et al. Consensus guidelines in the treatment of major depressive disorder. J Clin Psychiatry. 1998; 59(suppl 20):73-84. PubMed (Pubitemid 29001831)
18. Rush A, Trivedi M. Treating depression to remission. Psychiatr Ann. 1995;25(12):704-709.
19. Stahl SM. Why settle for silver, when you can go for gold? response vs recovery as the goal of antidepressant therapy. J Clin Psychiatry. 1999;60(4):213-214. doi:10.408/JCP.v60n0401 PubMed (Pubitemid 29193916)
20. Thase ME. Evaluating antidepressant therapies: remission as the optimal outcome. J Clin Psychiatry. 2003;64(suppl 13):18-25. PubMed (Pubitemid 37267811)
21. Kurian BT, Greer TL, Trivedi MH. Strategies to enhance the therapeutic efficacy of antidepressants: targeting residual symptoms. Expert Rev Neurother. 2009;9(7):975-984. doi:10.1586/ern.09.53 PubMed
22. Möller HJ. Outcomes in major depressive disorder: the evolving concept of remission and its implications for treatment. World J Biol Psychiatry. 2008;9(2):102-114. doi:10.1080/1562970801981606 PubMed
23. McIntyre RS, Fallu A, Konarski JZ. Measurable outcomes in psychiatric disorders: remission as a marker of wellness. Clin Ther. 2006;28(11): 1882-1891. doi:10.1016/j.clinthera.206.1.07 PubMed (Pubitemid 46043505)
24. Judd LL, Paulus MJ, Schettler PJ, et al. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry. 2000;157(9):1501-1504. doi:10.176/api.ajp.157.9.1501 PubMed
25. Zimmerman M, Posternak MA, Chelminski I. Is the cutoff to define remission on the Hamilton Rating Scale for Depression too high? J Nerv Ment Dis. 2005;193(3):170-175. doi:10.1097/01.nmd.0154840.63529.5d PubMed (Pubitemid 40354840)
26. Nierenberg AA, Husain MM, Trivedi MH, et al. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. Psychol Med. 2010;40(1):41-50. doi:10.1017/S032917090601 PubMed
27. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573-583. doi:10.1016/S06-323(02)0186-8 PubMed (Pubitemid 37289444)
28. Zimmerman M, McGlinchey JB, Posternak MA, et al. How should remission from depression be defined? the depressed patient's perspective. Am J Psychiatry. 2006;163(1):148-150. doi:10.176/api.ajp.163.1.148 PubMed (Pubitemid 43050117)
29. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/P, version 2.0). New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1995.
30. Zimmerman M, Posternak MA, Chelminski I. Heterogeneity among depressed outpatients considered to be in remission. Compr Psychiatry. 2007;48(2):113-117. doi:10.1016/j.compsych.206.10.05 PubMed (Pubitemid 46204672)
31. Zimmerman M, Chelminski I, McGlinchey JB, et al. A Clinically Useful Depression Outcome Scale. Compr Psychiatry. 2008;49(2):131-140. doi:10.1016/j.compsych.207.10.06 PubMed
32. Zimmerman M, Chelminski I, Young D, et al. A Clinically Useful Anxiety Outcome Scale. J Clin Psychiatry. 2010;71(5):534-542. doi:10.408/JCP.09m05264blu PubMed
33. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976.
34. Zimmerman M, Sheeran T, Young D. The Diagnostic Inventory for Depression: a self-report scale to diagnose DSM-IV major depressive disorder. J Clin Psychol. 2004;60(1):87-110. doi:10.102/jclp.10207 PubMed (Pubitemid 38009994)
35. Zimmerman M, Galione J, Attiullah N, et al. Depressed patients perspectives of two measures of outcome: the Quick Inventory of Depressive Symptomatology (QIDS) and the Remission from Depression Questionnaire (RDQ). Ann Clin Psychiatry. 2011:23(3):208-212.
36. Trivedi MH, Rush AJ, Wisniewski SR, et al; STAR*D Study Team. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28-40. doi:10.176/api.ajp.163.1.28 PubMed (Pubitemid 43050100)
37. Rush AJ, Trivedi MH, Stewart JW, et al. Combining Medications to Enhance Depression Outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry. 2011; 168(7):689-701.
38. Rush AJ, Fava M, Wisniewski SR, et al; STAR*D Investigators Group. Sequenced Treatment Alternatives to Relieve Depression (STAR*D): rationale and design. Control Clin Trials. 2004;25(1):119-142. doi:10.1016/S0197-2456(03) 012-0 PubMed (Pubitemid 38230109)
39. Zimmerman M, McGlinchey JB, Chelminski I. An inadequate community standard of care: lack of measurement of outcome when treating depression in clinical practice. Prim Psychiatry. 2008;15:67-75. (Pubitemid 351847591)
40. Zimmerman M, Young D, Chelminski I, et al. How can you improve quality without measuring outcome? getting from here to there. Prim Psychiatry. 2010;17:46-53.
41. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163(11):1905-1917. doi:10.176/api.ajp.163.1.1905 PubMed (Pubitemid 44807782)
42. Zimmerman M, Mattia JI, Posternak MA. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? Am J Psychiatry. 2002;159(3):469-473. doi:10.176/api.ajp.159.3.469 PubMed (Pubitemid 34184745)